- Home
- GOGO vs GLPG Comparison
GOGO vs GLPG Comparison
Compare GOGO & GLPG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GOGO
- GLPG
- Stock Information
- Founded
- GOGO 1991
- GLPG 1999
- Country
- GOGO United States
- GLPG Belgium
- Employees
- GOGO N/A
- GLPG N/A
- Industry
- GOGO Telecommunications Equipment
- GLPG Biotechnology: Pharmaceutical Preparations
- Sector
- GOGO Consumer Discretionary
- GLPG Health Care
- Exchange
- GOGO Nasdaq
- GLPG Nasdaq
- Market Cap
- GOGO 2.0B
- GLPG 2.0B
- IPO Year
- GOGO 2013
- GLPG 2005
- Fundamental
- Price
- GOGO $15.78
- GLPG $32.65
- Analyst Decision
- GOGO Buy
- GLPG Sell
- Analyst Count
- GOGO 3
- GLPG 4
- Target Price
- GOGO $11.33
- GLPG $25.33
- AVG Volume (30 Days)
- GOGO 1.6M
- GLPG 303.7K
- Earning Date
- GOGO 08-07-2025
- GLPG 07-23-2025
- Dividend Yield
- GOGO N/A
- GLPG N/A
- EPS Growth
- GOGO N/A
- GLPG N/A
- EPS
- GOGO N/A
- GLPG N/A
- Revenue
- GOGO $570,694,000.00
- GLPG $323,721,668.00
- Revenue This Year
- GOGO $107.44
- GLPG $0.78
- Revenue Next Year
- GOGO $5.66
- GLPG N/A
- P/E Ratio
- GOGO N/A
- GLPG N/A
- Revenue Growth
- GOGO 41.51
- GLPG 5.45
- 52 Week Low
- GOGO $6.17
- GLPG $22.36
- 52 Week High
- GOGO $16.61
- GLPG $33.86
- Technical
- Relative Strength Index (RSI)
- GOGO 61.20
- GLPG 64.71
- Support Level
- GOGO $15.17
- GLPG $28.78
- Resistance Level
- GOGO $16.61
- GLPG $33.86
- Average True Range (ATR)
- GOGO 0.62
- GLPG 0.83
- MACD
- GOGO -0.14
- GLPG 0.20
- Stochastic Oscillator
- GOGO 46.79
- GLPG 78.58
About GOGO Gogo Inc.
Gogo Inc is a broadband connectivity service for the business aviation market. It provides a customizable suite of smart cabin systems for integrated connectivity, inflight entertainment, and voice solutions. Its business segment includes Gogo BA and Satcom Direct. It generates two types of revenue: service revenue consists of monthly subscription and usage fees paid by aircraft owners and operators for telecommunication, data, and in-flight entertainment services, and equipment revenue consists of proceeds from the sale of ATG and narrowband satellite connectivity equipment and is recognized when control of the equipment is transferred to OEMs and dealers, which generally occurs when the equipment is shipped.
About GLPG Galapagos NV
Galapagos NV is a fully integrated biotechnology company with operations in Europe and the United States, dedicated to developing medicines focusing on oncology and immunology. The group focuses on unmet medical needs, it synergizes compelling science, technology, and collaborative approaches to create a deep pipeline of medicines. Its clinical pipeline includes: GLPG5101, a CD19 CAR-T product candidate decentralized manufactured, currently in Phase 1/2 in rrNHL; GLPG5301, a BCMA CAR-T product candidate decentralized manufactured, currently in Phase 1 in rrMM; and GLPG3667, a TYK2 inhibitor currently in Phase 2 clinical trial in DM and SLE. It derives maximum revenue from the United States of America.